Dr. Jeffrey Klausner is a clinical professor of Population and Public Health Sciences at the University of Southern California (USC) Keck School of Medicine.
In 2021, Facente Consulting was hired to take notes of a national meeting of U.S. experts exploring the potential of fluvoxamine as an early treatment for COVID-19, and turn the meeting outcomes into a peer-reviewed publication in a high-profile clinical journal.